cached image

Steven E. Arnold, MD - Publications

Center for Neurobiology and Behavior University of Pennsylvania, Philadelphia, PA, United States 
Cellular and molecular neurobiology of schizophrenia and mood disorders, aging and neurodegenerative dementias

174 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98. PMID 30253800 DOI: 10.1186/S13195-018-0426-3  0.44
2018 Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, ... ... Arnold SE, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain : a Journal of Neurology. PMID 29878075 DOI: 10.1093/Brain/Awy146  0.4
2018 Trombetta BA, Carlyle BC, Koenig AM, Shaw LM, Trojanowski JQ, Wolk DA, Locascio JJ, Arnold SE. The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease. Plos One. 13: e0193707. PMID 29505610 DOI: 10.1371/Journal.Pone.0193707  0.44
2018 Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Arnold SE, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103  0.4
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Arnold SE, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391  0.44
2017 Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE. Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study. Alzheimer Disease and Associated Disorders. 31: 107-113. PMID 28538088 DOI: 10.1097/Wad.0000000000000202  0.44
2017 Roalf DR, Moore TM, Mechanic-Hamilton D, Wolk DA, Arnold SE, Weintraub DA, Moberg PJ. Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28238740 DOI: 10.1016/J.Jalz.2017.01.015  0.44
2016 Quarmley M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, Arnold SE, Wolk DA, Roalf DR. Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27886011 DOI: 10.3233/Jad-160842  0.44
2016 Roalf DR, Quarmley M, Mechanic-Hamilton D, Wolk DA, Arnold SE, Moberg PJ. Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 54: 325-35. PMID 27567827 DOI: 10.3233/Jad-160259  0.44
2016 Choi CH, Schoenfeld BP, Bell AJ, Hinchey J, Rosenfelt C, Gertner MJ, Campbell SR, Emerson D, Hinchey P, Kollaros M, Ferrick NJ, Chambers DB, Langer S, Sust S, Malik A, ... ... Arnold SE, et al. Multiple Drug Treatments That Increase cAMP Signaling Restore Long-Term Memory and Aberrant Signaling in Fragile X Syndrome Models. Frontiers in Behavioral Neuroscience. 10: 136. PMID 27445731 DOI: 10.3389/Fnbeh.2016.00136  0.44
2016 Roalf DR, Moore TM, Wolk DA, Arnold SE, Mechanic-Hamilton D, Rick J, Kabadi S, Ruparel K, Chen-Plotkin AS, Chahine LM, Dahodwala NA, Duda JE, Weintraub DA, Moberg PJ. Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27071646 DOI: 10.1136/Jnnp-2015-312723  0.44
2016 Ridge PG, Hoyt KB, Boehme K, Mukherjee S, Crane PK, Haines JL, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD, Kauwe JS. Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiology of Aging. PMID 27036079 DOI: 10.1016/J.Neurobiolaging.2016.02.024  0.44
2015 Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, et al. Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology. Acta Neuropathologica. PMID 26721587 DOI: 10.1007/S00401-015-1526-9  0.44
2015 Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE, Van Deerlin VM, Seeley WW, Miller BL, Lee EB, Lee VM, Grossman M, Trojanowski JQ. Deep Clinical and Neuropathological Phenotyping of Pick's Disease. Annals of Neurology. PMID 26583316 DOI: 10.1002/Ana.24559  0.44
2015 Egbujo CN, Sinclair D, Borgmann-Winter KE, Arnold SE, Turetsky BI, Hahn CG. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia. Schizophrenia Research. 168: 554-62. PMID 26260078 DOI: 10.1016/J.Schres.2015.07.026  0.44
2015 Toledo JB, Bjerke M, Chen K, Rozycki M, Jack CR, Weiner MW, Arnold SE, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Memory, executive, and multidomain subtle cognitive impairment: Clinical and biomarker findings. Neurology. 85: 144-53. PMID 26085606 DOI: 10.1016/J.Jalz.2015.06.1758  0.44
2015 Negash S, Kliot D, Howard DV, Howard JH, Das SR, Yushkevich PA, Pluta JB, Arnold SE, Wolk DA. Relationship of contextual cueing and hippocampal volume in amnestic mild cognitive impairment patients and cognitively normal older adults. Journal of the International Neuropsychological Society : Jins. 21: 285-96. PMID 25991413 DOI: 10.1017/S1355617715000223  0.44
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668  0.44
2015 Kandel BM, Avants BB, Gee JC, Arnold SE, Wolk DA. Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 25881908 DOI: 10.3233/Jad-142943  0.44
2015 Das SR, Mancuso L, Olson IR, Arnold SE, Wolk DA. Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment. Cerebral Cortex (New York, N.Y. : 1991). PMID 25725042 DOI: 10.1093/Cercor/Bhv022  0.44
2015 Steinberg SI, Sammel MD, Harel BT, Schembri A, Policastro C, Bogner HR, Negash S, Arnold SE. Exercise, sedentary pastimes, and cognitive performance in healthy older adults. American Journal of Alzheimer's Disease and Other Dementias. 30: 290-8. PMID 25100746 DOI: 10.1177/1533317514545615  0.44
2015 Moelter ST, Glenn MA, Xie SX, Chittams J, Clark CM, Watson M, Arnold SE. The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores. Alzheimer Disease and Associated Disorders. 29: 158-60. PMID 24770371 DOI: 10.1097/Wad.0000000000000031  0.44
2015 Kansal K, Kamath V, Mechanic-Hamilton D, Irwin DJ, Moberg PJ, Turetsky BI, Grossman M, Arnold SE, Onyike CU. Odor identification in frontotemporal dementia, Alzheimer’s disease, and major depression Alzheimers & Dementia. 11: 375. DOI: 10.1016/J.Jalz.2015.06.292  0.36
2015 Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, ... ... Arnold SE, et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 1: 339-348. DOI: 10.1016/j.dadm.2015.06.008  0.44
2014 Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/S00401-014-1349-0  0.44
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Arnold SE, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491  0.44
2014 Glenn M, Mace L, Shaw L, Arnold S, Wolk D, Moelter S. A-79Primacy-Weighted Retrieval Differences in Healthy Older Adults with Pathological or Normal Cerebrospinal Fluid Markers of Alzheimer's Disease. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 532. PMID 25176741 DOI: 10.1093/Arclin/Acu038.79  0.4
2014 Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, Louneva N, Lee VM, Kim SF, Trojanowski JQ, Arnold SE. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathologica. 128: 679-89. PMID 25107476 DOI: 10.1007/S00401-014-1328-5  0.44
2014 Wilson RS, Capuano AW, Boyle PA, Hoganson GM, Hizel LP, Shah RC, Nag S, Schneider JA, Arnold SE, Bennett DA. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 83: 702-9. PMID 25080520 DOI: 10.1212/Wnl.0000000000000715  0.44
2014 Irwin DJ, McMillan CT, Suh E, Powers J, Rascovsky K, Wood EM, Toledo JB, Arnold SE, Lee VM, Van Deerlin VM, Trojanowski JQ, Grossman M. Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia. Neurology. 83: 502-9. PMID 24994843 DOI: 10.1212/Wnl.0000000000000668  0.44
2014 Bit-Ivan EN, Suh E, Shim HS, Weintraub S, Hyman BT, Arnold SE, McCarty-Wood E, Van Deerlin VM, Schneider JA, Trojanowski JQ, Frosch MP, Baker MC, Rademakers R, Mesulam M, Bigio EH. A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases. Journal of Neuropathology and Experimental Neurology. 73: 467-73. PMID 24709683 DOI: 10.1097/Nen.0000000000000070  0.44
2014 Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR, Chen Y, McMullen MF, Kim SF. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiology of Disease. 67: 79-87. PMID 24686304 DOI: 10.1016/J.Nbd.2014.03.011  0.44
2014 Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathologica Communications. 2: 26. PMID 24602322 DOI: 10.1186/2051-5960-2-26  0.44
2014 Toledo JB, Da X, Weiner MW, Wolk DA, Xie SX, Arnold SE, Davatzikos C, Shaw LM, Trojanowski JQ. CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathologica. 127: 621-32. PMID 24385135 DOI: 10.1007/S00401-013-1236-0  0.44
2014 Bennett DA, Arnold SE, Valenzuela MJ, Brayne C, Schneider JA. Cognitive and social lifestyle: links with neuropathology and cognition in late life. Acta Neuropathologica. 127: 137-50. PMID 24356982 DOI: 10.1007/S00401-013-1226-2  0.44
2014 Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R, Smith MA, Lee HG, Arnold SE, Casadesus G. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition. Neurobiology of Aging. 35: 793-801. PMID 24239383 DOI: 10.1016/J.Neurobiolaging.2013.10.076  0.44
2014 Toledo JB, Van Deerlin VM, Lee EB, Suh E, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T, Irwin DJ, Gross RG, Hurtig H, McCluskey L, Elman L, ... ... Arnold SE, et al. A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 477-84.e1. PMID 23978324 DOI: 10.1016/J.Jalz.2013.06.003  0.44
2013 Wolk DA, Manning K, Kliot D, Arnold SE. Recognition memory in amnestic-mild cognitive impairment: insights from event-related potentials. Frontiers in Aging Neuroscience. 5: 89. PMID 24376418 DOI: 10.3389/Fnagi.2013.00089  0.44
2013 Steinberg SI, Negash S, Sammel MD, Bogner H, Harel BT, Livney MG, McCoubrey H, Wolk DA, Kling MA, Arnold SE. Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults. American Journal of Alzheimer's Disease and Other Dementias. 28: 776-83. PMID 24363073 DOI: 10.1177/1533317513504817  0.44
2013 Motsinger-Reif AA, Zhu H, Kling MA, Matson W, Sharma S, Fiehn O, Reif DM, Appleby DH, Doraiswamy PM, Trojanowski JQ, Kaddurah-Daouk R, Arnold SE. Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging. Acta Neuropathologica Communications. 1: 28. PMID 24252434 DOI: 10.1186/2051-5960-1-28  0.44
2013 Wang Z, Das SR, Xie SX, Arnold SE, Detre JA, Wolk DA. Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study. Neuroimage. Clinical. 2: 630-6. PMID 24179814 DOI: 10.1016/J.Nicl.2013.04.014  0.44
2013 Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L, Buchman AS, Shah RC, Schneider JA, Arnold SE, Bennett DA. Brainstem aminergic nuclei and late-life depressive symptoms. Jama Psychiatry. 70: 1320-8. PMID 24132763 DOI: 10.1001/Jamapsychiatry.2013.2224  0.44
2013 Pantazopoulos H, Boyer-Boiteau A, Holbrook EH, Jang W, Hahn CG, Arnold SE, Berretta S. Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia. Schizophrenia Research. 150: 366-72. PMID 24035561 DOI: 10.1016/J.Schres.2013.08.013  0.44
2013 Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, Chen-Plotkin A, Wolk DA, Arnold SE. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. Journal of the Neurological Sciences. 333: 9-12. PMID 23978419 DOI: 10.1016/J.Jns.2013.05.028  0.44
2013 Negash S, Wilson RS, Leurgans SE, Wolk DA, Schneider JA, Buchman AS, Bennett DA, Arnold SE. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Current Alzheimer Research. 10: 844-51. PMID 23919768 DOI: 10.2174/15672050113109990157  0.44
2013 Irwin DJ, Cohen TJ, Grossman M, Arnold SE, McCarty-Wood E, Van Deerlin VM, Lee VM, Trojanowski JQ. Acetylated tau neuropathology in sporadic and hereditary tauopathies. The American Journal of Pathology. 183: 344-51. PMID 23885714 DOI: 10.1016/J.Ajpath.2013.04.025  0.44
2013 Arnold SE, Toledo JB, Appleby DH, Xie SX, Wang LS, Baek Y, Wolk DA, Lee EB, Miller BL, Lee VM, Trojanowski JQ. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. The Journal of Comparative Neurology. 521: 4339-55. PMID 23881776 DOI: 10.1002/Cne.23430  0.44
2013 Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA, Trojanowski JQ. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain : a Journal of Neurology. 136: 2697-706. PMID 23842566 DOI: 10.1093/Brain/Awt188  0.44
2013 Kaddurah-Daouk R, Zhu H, Sharma S, Bogdanov M, Rozen SG, Matson W, Oki NO, Motsinger-Reif AA, Churchill E, Lei Z, Appleby D, Kling MA, Trojanowski JQ, Doraiswamy PM, Arnold SE, et al. Alterations in metabolic pathways and networks in Alzheimer's disease. Translational Psychiatry. 3: e244. PMID 23571809 DOI: 10.1038/Tp.2013.18  0.44
2013 Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, ... ... Arnold SE, et al. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 78: 256-68. PMID 23562540 DOI: 10.1016/J.Neuron.2013.02.026  0.44
2013 Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC. Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. Neuropsychologia. 51: 1094-102. PMID 23474075 DOI: 10.1016/J.Neuropsychologia.2013.02.014  0.44
2013 Berlau DJ, Corrada MM, Robinson JL, Geser F, Arnold SE, Lee VM, Kawas CH, Trojanowski JQ. Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 699-705. PMID 23474043 DOI: 10.1016/J.Jalz.2012.11.011  0.44
2013 Toledo JB, Da X, Bhatt P, Wolk DA, Arnold SE, Shaw LM, Trojanowski JQ, Davatzikos C. Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI. Plos One. 8: e55531. PMID 23408997 DOI: 10.1371/Journal.Pone.0055531  0.44
2013 Seligman SC, Kamath V, Giovannetti T, Arnold SE, Moberg PJ. Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults. Aging & Mental Health. 17: 564-70. PMID 23398350 DOI: 10.1080/13607863.2013.768208  0.44
2013 Buchman AS, Boyle PA, Wilson RS, Leurgans SE, Arnold SE, Bennett DA. Neuroticism, extraversion, and motor function in community-dwelling older persons. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 145-54. PMID 23343488 DOI: 10.1016/J.Jagp.2012.10.015  0.44
2013 Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 529-37. PMID 23260866 DOI: 10.1016/J.Jalz.2012.10.001  0.44
2013 Kling MA, Trojanowski JQ, Wolk DA, Lee VM, Arnold SE. Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 76-92. PMID 23183137 DOI: 10.1016/J.Jalz.2012.02.007  0.44
2013 Negash S, Xie S, Davatzikos C, Clark CM, Trojanowski JQ, Shaw LM, Wolk DA, Arnold SE. Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e89-95. PMID 23127468 DOI: 10.1016/J.Jalz.2012.01.009  0.44
2013 Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, Toledo JB, Boller A, Bekisz J, Chandrasekaran K, Wood EM, Shaw LM, Woo JH, Cook PA, Wolk DA, ... Arnold SE, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 163-9. PMID 23117491 DOI: 10.1136/Jnnp-2012-303507  0.44
2013 Arnold SE, Vega IE, Karlawish JH, Wolk DA, Nunez J, Negron M, Xie SX, Wang LS, Dubroff JG, McCarty-Wood E, Trojanowski JQ, Van Deerlin V. Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia. Journal of Alzheimer's Disease : Jad. 33: 1089-95. PMID 23114514 DOI: 10.3233/Jad-2012-121570  0.44
2013 Arnold SE, Louneva N, Cao K, Wang LS, Han LY, Wolk DA, Negash S, Leurgans SE, Schneider JA, Buchman AS, Wilson RS, Bennett DA. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiology of Aging. 34: 157-68. PMID 22554416 DOI: 10.1016/J.Neurobiolaging.2012.03.004  0.44
2012 Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM, Trojanowski JQ, Arnold SE. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain : a Journal of Neurology. 135: 3749-56. PMID 23204143 DOI: 10.1093/Brain/Aws271  0.44
2012 Whitcomb DC, LaRusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, Alkaade S, Amann ST, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nature Genetics. 44: 1349-54. PMID 23143602 DOI: 10.1038/Ng.2466  0.44
2012 Trojanowski JQ, Arnold SE, Karlawish JH, Naylor M, Brunden KR, Lee VM. A model for improving the treatment and care of Alzheimer's disease patients through interdisciplinary research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 564-73. PMID 23102127 DOI: 10.1016/J.Jalz.2011.08.005  0.44
2012 Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, Smith A, McLain R, Sherwin PF, Farrar G, Kailajärvi M, Grachev ID. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathologica. 124: 833-45. PMID 23053137 DOI: 10.1007/S00401-012-1051-Z  0.44
2012 Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52. PMID 22959699 DOI: 10.1016/J.Jalz.2012.08.001  0.44
2012 Zhang Q, Stafford RB, Wang Z, Arnold SE, Wolk DA, Detre JA. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 32: 677-87. PMID 22886015 DOI: 10.3233/Jad-2012-120964  0.44
2012 Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, et al. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology. 79: 897-905. PMID 22855860 DOI: 10.1212/Wnl.0B013E318266Fa70  0.44
2012 Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VM, Mackin RS, Trojanowski JQ, et al. Plasma biomarkers of depressive symptoms in older adults. Translational Psychiatry. 2: e65. PMID 22832727 DOI: 10.1038/Tp.2011.63  0.44
2012 Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 923-6. PMID 22791901 DOI: 10.1136/Jnnp-2012-302548  0.44
2012 Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 261-71. PMID 22672770 DOI: 10.1016/J.Jalz.2011.09.224  0.44
2012 Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX, Lee VM, Shaw LM, Trojanowski JQ. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathologica. 124: 23-35. PMID 22526019 DOI: 10.1007/S00401-012-0983-7  0.44
2012 Irwin DJ, McMillan CT, Toledo JB, Arnold SE, Shaw LM, Wang LS, Van Deerlin V, Lee VM, Trojanowski JQ, Grossman M. Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Archives of Neurology. 69: 1018-25. PMID 22490326 DOI: 10.1001/Archneurol.2012.26  0.44
2012 Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, ... Arnold SE, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. The Journal of Clinical Investigation. 122: 1316-38. PMID 22476197 DOI: 10.1172/Jci59903  0.44
2012 Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. The Journal of Clinical Investigation. 122: 1339-53. PMID 22476196 DOI: 10.1172/Jci57256  0.44
2012 Patel S, Lee EB, Xie SX, Law A, Jackson EM, Arnold SE, Clark CM, Shaw LM, Grady MS, Trojanowski JQ, Hamilton RH. Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids and Barriers of the Cns. 9: 7. PMID 22444461 DOI: 10.1186/2045-8118-9-7  0.44
2012 Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA. Nigral pathology and parkinsonian signs in elders without Parkinson disease. Annals of Neurology. 71: 258-66. PMID 22367997 DOI: 10.1002/Ana.22588  0.44
2012 Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, Trojanowski JQ. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain : a Journal of Neurology. 135: 807-18. PMID 22366796 DOI: 10.1093/Brain/Aws013  0.44
2012 Chin AL, Negash S, Xie S, Arnold SE, Hamilton R. Quality, and not just quantity, of education accounts for differences in psychometric performance between african americans and white non-hispanics with Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 18: 277-85. PMID 22300593 DOI: 10.1017/S1355617711001688  0.44
2012 Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 51-9. PMID 22018493 DOI: 10.1016/J.Jalz.2011.06.003  0.44
2012 Arnold S, Rinne J, Wong D, Leinonen V, Wolk D, Buckley C, Smith A, McLain R, Sherwin P, Farrar G, Kailajarvi M, Grachev I. Prospective and retrospective evaluation of [18F]Flutemetamol for beta-amyloid detection in the brain of living subjects with normal pressure hydrocephalus Alzheimers & Dementia. 8: 91. DOI: 10.1016/J.Jalz.2012.05.224  0.4
2011 Robinson JL, Geser F, Corrada MM, Berlau DJ, Arnold SE, Lee VM, Kawas CH, Trojanowski JQ. Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain : a Journal of Neurology. 134: 3708-15. PMID 22120149 DOI: 10.1093/Brain/Awr308  0.44
2011 Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology. 77: 1977-85. PMID 22094481 DOI: 10.1212/Wnl.0B013E31823A0Ef7  0.44
2011 Carlson GC, Talbot K, Halene TB, Gandal MJ, Kazi HA, Schlosser L, Phung QH, Gur RE, Arnold SE, Siegel SJ. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 108: E962-70. PMID 21969553 DOI: 10.1073/Pnas.1109625108  0.44
2011 Xie SX, Baek Y, Grossman M, Arnold SE, Karlawish J, Siderowf A, Hurtig H, Elman L, McCluskey L, Van Deerlin V, Lee VM, Trojanowski JQ. Building an integrated neurodegenerative disease database at an academic health center. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e84-93. PMID 21784346 DOI: 10.1016/J.Jalz.2010.08.233  0.44
2011 Wolk DA, Grachev ID, Buckley C, Kazi H, Grady MS, Trojanowski JQ, Hamilton RH, Sherwin P, McLain R, Arnold SE. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Archives of Neurology. 68: 1398-403. PMID 21747004 DOI: 10.1001/Archneurol.2011.153  0.44
2011 Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics. 43: 699-705. PMID 21685912 DOI: 10.1038/Ng.859  0.44
2011 Livney MG, Clark CM, Karlawish JH, Cartmell S, Negrón M, Nuñez J, Xie SX, Entenza-Cabrera F, Vega IE, Arnold SE. Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 430-9. PMID 21522051 DOI: 10.1097/Jgp.0B013E3181F7D881  0.44
2011 Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Van Deerlin VM, Lee VM, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Annals of Neurology. 69: 655-63. PMID 21520231 DOI: 10.1002/Ana.22271  0.44
2011 Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, ... ... Arnold SE, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 43: 436-41. PMID 21460841 DOI: 10.1038/Ng.801  0.44
2011 Talbot K, Louneva N, Cohen JW, Kazi H, Blake DJ, Arnold SE. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location. Plos One. 6: e16886. PMID 21390302 DOI: 10.1371/Journal.Pone.0016886  0.44
2011 Cohen JW, Louneva N, Han LY, Hodes GE, Wilson RS, Bennett DA, Lucki I, Arnold SE. Chronic corticosterone exposure alters postsynaptic protein levels of PSD-95, NR1, and synaptopodin in the mouse brain. Synapse (New York, N.Y.). 65: 763-70. PMID 21190219 DOI: 10.1002/Syn.20900  0.44
2011 Womack KB, Diaz-Arrastia R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Clark CM, DeCarli CS, Jagust WJ, Leverenz JB, Peskind ER, Turner RS, Zamrini EY, Heidebrink JL, Burke JR, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Archives of Neurology. 68: 329-37. PMID 21059987 DOI: 10.1001/Archneurol.2010.295  0.44
2011 Wolk D, Grachev I, Buckley C, Heurling K, Hamilton R, Arnold S. [18F]-Flutemetamol amyloid PET imaging in patients with normal pressure hydrocephalus Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2099  0.4
2010 Gabel MJ, Foster NL, Heidebrink JL, Higdon R, Aizenstein HJ, Arnold SE, Barbas NR, Boeve BF, Burke JR, Clark CM, Dekosky ST, Farlow MR, Jagust WJ, Kawas CH, Koeppe RA, et al. Validation of consensus panel diagnosis in dementia. Archives of Neurology. 67: 1506-12. PMID 21149812 DOI: 10.1001/Archneurol.2010.301  0.44
2010 Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ. Novel CSF biomarkers for frontotemporal lobar degenerations. Neurology. 75: 2079-86. PMID 21048198 DOI: 10.1016/J.Jalz.2010.05.253  0.44
2010 Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EM, Van Deerlin VM, Lee VM, Arnold SE, Trojanowski JQ. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Archives of Neurology. 67: 1238-50. PMID 20937952 DOI: 10.1001/Archneurol.2010.254  0.44
2010 Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A, Shaw LM, Xie SX, Grady MS, Trojanowski JQ. Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Annals of Neurology. 68: 535-40. PMID 20687117 DOI: 10.1002/Ana.22015  0.44
2010 Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathologica. 120: 385-99. PMID 20652578 DOI: 10.1007/S00401-010-0723-9  0.44
2010 Soetanto A, Wilson RS, Talbot K, Un A, Schneider JA, Sobiesk M, Kelly J, Leurgans S, Bennett DA, Arnold SE. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Archives of General Psychiatry. 67: 448-57. PMID 20439826 DOI: 10.1001/Archgenpsychiatry.2010.48  0.44
2010 Arnold SE, Lee EB, Moberg PJ, Stutzbach L, Kazi H, Han LY, Lee VM, Trojanowski JQ. Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Annals of Neurology. 67: 462-9. PMID 20437581 DOI: 10.1002/Ana.21910  0.44
2010 Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, Davatzikos C, Detre J, Gaulton G, Grossman M, Hurtig H, Jedrziewski K, McCluskey L, Naylor M, Polsky D, Schellenberg GD, et al. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 150-5. PMID 20298979 DOI: 10.1016/J.Jalz.2009.11.004  0.44
2010 Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, Pickering E, Kuhn M, Chen Y, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, et al. Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Acta Neuropathologica. 119: 669-78. PMID 20232070 DOI: 10.1007/S00401-010-0667-0  0.44
2010 Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nature Genetics. 42: 234-9. PMID 20154673 DOI: 10.1038/Ng.536  0.44
2010 Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, ... ... Arnold SE, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Archives of Neurology. 67: 161-70. PMID 20142524 DOI: 10.1001/Archneurol.2009.328  0.44
2009 Xie SX, Ewbank DC, Chittams J, Karlawish JH, Arnold SE, Clark CM. Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale. Alzheimer Disease and Associated Disorders. 23: 268-74. PMID 19812470 DOI: 10.1097/Wad.0B013E318194A324  0.44
2009 Hahn CG, Banerjee A, Macdonald ML, Cho DS, Kamins J, Nie Z, Borgmann-Winter KE, Grosser T, Pizarro A, Ciccimaro E, Arnold SE, Wang HY, Blair IA. The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses. Plos One. 4: e5251. PMID 19370153 DOI: 10.1371/Journal.Pone.0005251  0.44
2009 Turetsky BI, Hahn CG, Arnold SE, Moberg PJ. Olfactory receptor neuron dysfunction in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 767-74. PMID 18754006 DOI: 10.1038/Npp.2008.139  0.44
2008 Fairless AH, Dow HC, Toledo MM, Malkus KA, Edelmann M, Li H, Talbot K, Arnold SE, Abel T, Brodkin ES. Low sociability is associated with reduced size of the corpus callosum in the BALB/cJ inbred mouse strain. Brain Research. 1230: 211-7. PMID 18662677 DOI: 10.1016/J.Brainres.2008.07.025  0.44
2008 Wilson RS, Arnold SE, Beck TL, Bienias JL, Bennett DA. Change in depressive symptoms during the prodromal phase of Alzheimer disease. Archives of General Psychiatry. 65: 439-45. PMID 18391132 DOI: 10.1001/Archpsyc.65.4.439  0.44
2008 Xie SX, Forman MS, Farmer J, Moore P, Wang Y, Wang X, Clark CM, Coslett HB, Chatterjee A, Arnold SE, Rosen H, Karlawish JH, Van Deerlin VM, Lee VM, Trojanowski JQ, et al. Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 126-9. PMID 17615171 DOI: 10.1136/Jnnp.2006.110288  0.44
2008 Cartmell SP, Xie SX, Martinez P, Nunez J, Janis P, Baek Y, Karlawish JHT, Arnold SE, Clark CM. P3-007: Instability of a diagnosis of mild cognitive impairment based on a brief screening assessment of English- and Spanish-speaking individuals in a general care clinic Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1570  0.4
2007 Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR, DeCarli CS, Turner RS, Koeppe RA, Higdon R, Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain : a Journal of Neurology. 130: 2616-35. PMID 17704526 DOI: 10.1093/Brain/Awm177  0.44
2007 Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica. 114: 221-9. PMID 17653732 DOI: 10.1007/S00401-007-0261-2  0.44
2007 Gur RE, Turetsky BI, Loughead J, Snyder W, Kohler C, Elliott M, Pratiwadi R, Ragland JD, Bilker WB, Siegel SJ, Kanes SJ, Arnold SE, Gur RC. Visual attention circuitry in schizophrenia investigated with oddball event-related functional magnetic resonance imaging. The American Journal of Psychiatry. 164: 442-9. PMID 17329469 DOI: 10.1176/Ajp.2007.164.3.442  0.44
2007 O'Connor JA, Muly EC, Arnold SE, Hemby SE. AMPA receptor subunit and splice variant expression in the DLPFC of schizophrenic subjects and rhesus monkeys chronically administered antipsychotic drugs. Schizophrenia Research. 90: 28-40. PMID 17141476 DOI: 10.1016/J.Schres.2006.10.004  0.44
2007 Gur RC, Turetsky BI, Loughead J, Waxman J, Snyder W, Ragland JD, Elliott MA, Bilker WB, Arnold SE, Gur RE. Hemodynamic responses in neural circuitries for detection of visual target and novelty: An event-related fMRI study. Human Brain Mapping. 28: 263-74. PMID 17133387 DOI: 10.1002/Hbm.20319  0.44
2007 Overall KL, Arnold SE. Olfactory neuron biopsies in dogs: A feasibility pilot study Applied Animal Behaviour Science. 105: 351-357. DOI: 10.1016/j.applanim.2006.11.011  0.44
2006 Moberg PJ, Arnold SE, Doty RL, Gur RE, Balderston CC, Roalf DR, Gur RC, Kohler CG, Kanes SJ, Siegel SJ, Turetsky BI. Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures. Journal of Clinical and Experimental Neuropsychology. 28: 1444-61. PMID 17050269 DOI: 10.1080/13803390500434409  0.44
2006 Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nature Medicine. 12: 824-8. PMID 16767099 DOI: 10.1038/Nm1418  0.44
2006 Moberg PJ, Arnold SE, Roalf DR, Balderston CC, Abbazia J, Kohler CG, Gur RE, Turetsky BI. Apolipoprotein E genotype and odor identification in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 231-3. PMID 16720801 DOI: 10.1176/Jnp.2006.18.2.231  0.44
2006 Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin V, Lee VM, Miller BL, Trojanowski JQ, Grossman M. Frontotemporal dementia: clinicopathological correlations. Annals of Neurology. 59: 952-62. PMID 16718704 DOI: 10.1002/Ana.20873  0.44
2005 Francis PT, Nordberg A, Arnold SE. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends in Pharmacological Sciences. 26: 104-11. PMID 15681028 DOI: 10.1016/J.Tips.2004.12.010  0.44
2004 Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, Duyckaerts C, Stankoff B, Pillon B, Skullerud K, Cruz-Sanchez FF, Bigio EH, Mackenzie IR, Gearing M, Juncos JL, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology. 63: 1376-84. PMID 15505152 DOI: 10.1212/01.Wnl.0000139809.16817.Dd  0.44
2004 Cairns NJ, Uryu K, Bigio EH, Mackenzie IR, Gearing M, Duyckaerts C, Yokoo H, Nakazato Y, Jaros E, Perry RH, Arnold SE, Lee VM, Trojanowski JQ. alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases. Acta Neuropathologica. 108: 213-23. PMID 15170578 DOI: 10.1007/S00401-004-0882-7  0.44
2004 Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ, Hahn CG, Siegel SJ, Trojanowski JQ, Gur RE, Blake DJ, Arnold SE. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. The Journal of Clinical Investigation. 113: 1353-63. PMID 15124027 DOI: 10.1172/Jci20425  0.44
2004 Higdon R, Foster NL, Koeppe RA, DeCarli CS, Jagust WJ, Clark CM, Barbas NR, Arnold SE, Turner RS, Heidebrink JL, Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Statistics in Medicine. 23: 315-26. PMID 14716732 DOI: 10.1002/Sim.1719  0.44
2004 Clark CM, Xie S, Chittams J, Karlawish J, Arnold SE, Ewbank DC. P1-015 The dementia severity rating scale, a knowledgeable informant measure of dementia symptom severity, provides a reliable and clinically efficient measure of Alzheimer's disease progression from the time of initial evaluation to the severe impairment stage Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80329-4  0.4
2003 Turetsky BI, Moberg PJ, Roalf DR, Arnold SE, Gur RE. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Archives of General Psychiatry. 60: 1193-200. PMID 14662551 DOI: 10.1001/Archpsyc.60.12.1193  0.44
2003 Lowery N, Giovanni L, Mozley LH, Arnold SE, Bilker WB, Gur RE, Moberg PJ. Relationship between clock-drawing and neuropsychological and functional status in elderly institutionalized patients with schizophrenia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 621-8. PMID 14609802 DOI: 10.1176/Appi.Ajgp.11.6.621  0.44
2003 Moberg PJ, Arnold SE, Doty RL, Kohler C, Kanes S, Seigel S, Gur RE, Turetsky BI. Impairment of odor hedonics in men with schizophrenia. The American Journal of Psychiatry. 160: 1784-9. PMID 14514491 DOI: 10.1176/Appi.Ajp.160.10.1784  0.44
2003 Falke E, Nissanov J, Mitchell TW, Bennett DA, Trojanowski JQ, Arnold SE. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. The American Journal of Pathology. 163: 1615-21. PMID 14507668 DOI: 10.1016/S0002-9440(10)63518-3  0.44
2003 Schneider JA, Wilson RS, Cochran EJ, Bienias JL, Arnold SE, Evans DA, Bennett DA. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 60: 1082-8. PMID 12682310 DOI: 10.1212/01.Wnl.0000055863.87435.B2  0.44
2003 Turetsky BI, Moberg PJ, Arnold SE, Doty RL, Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. The American Journal of Psychiatry. 160: 703-8. PMID 12668359 DOI: 10.1176/Appi.Ajp.160.4.703  0.44
2003 Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, Bienias JL. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 60: 246-52. PMID 12552039 DOI: 10.1212/01.Wnl.0000042478.08543.F7  0.44
2003 Rioux L, Nissanov J, Lauber K, Bilker WB, Arnold SE. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. The American Journal of Psychiatry. 160: 149-55. PMID 12505814 DOI: 10.1176/Appi.Ajp.160.1.149  0.44
2002 Kapfhamer D, Valladares O, Sun Y, Nolan PM, Rux JJ, Arnold SE, Veasey SC, Bu?an M. Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nature Genetics. 32: 290-5. PMID 12244319 DOI: 10.1038/Ng991  0.44
2002 Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 59: 364-70. PMID 12177369 DOI: 10.1212/Wnl.59.3.364  0.44
2002 Hemby SE, Ginsberg SD, Brunk B, Arnold SE, Trojanowski JQ, Eberwine JH. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Archives of General Psychiatry. 59: 631-40. PMID 12090816 DOI: 10.1001/Archpsyc.59.7.631  0.44
2002 McBride T, Moberg PJ, Arnold SE, Mozley LH, Mahr RN, Gibney M, Kumar A, Gur RE. Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. Schizophrenia Research. 55: 217-27. PMID 12048145 DOI: 10.1016/S0920-9964(01)00232-8  0.44
2002 Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, Han LY, Bienias JL, Lee VM, Trojanowski JQ, Bennett DA, Arnold SE. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Annals of Neurology. 51: 182-9. PMID 11835374 DOI: 10.1002/Ana.10086  0.44
2001 Arnold SE, Han LY, Moberg PJ, Turetsky BI, Gur RE, Trojanowski JQ, Hahn CG. Dysregulation of olfactory receptor neuron lineage in schizophrenia. Archives of General Psychiatry. 58: 829-35. PMID 11545665 DOI: 10.1001/Archpsyc.58.9.829  0.44
2001 Kurtz MM, Moberg PJ, Mozley LH, Hickey T, Arnold SE, Bilker WB, Gur RE. Cognitive impairment and functional status in elderly institutionalized patients with schizophrenia. International Journal of Geriatric Psychiatry. 16: 631-8. PMID 11424173 DOI: 10.1002/Gps.394  0.44
2001 Arnold SE. Contributions of neuropathology to understanding schizophrenia in late life. Harvard Review of Psychiatry. 9: 69-76. PMID 11266404 DOI: 10.1080/10673220127882  0.44
2001 Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE, Masliah E, Galasko D, Trojanowski JQ, Lee VM. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Annals of Neurology. 49: 165-75. PMID 11220736 DOI: 10.1002/1531-8249(20010201)49:2<165::Aid-Ana36>3.0.Co;2-3  0.4
2000 Arnold SE, Han LY, Clark CM, Grossman M, Trojanowski JQ. Quantitative neurohistological features of frontotemporal degeneration. Neurobiology of Aging. 21: 913-9. PMID 11124442 DOI: 10.1016/S0197-4580(00)00173-1  0.4
2000 Mitchell TW, Nissanov J, Han LY, Mufson EJ, Schneider JA, Cochran EJ, Bennett DA, Lee VM, Trojanowski JQ, Arnold SE. Novel method to quantify neuropil threads in brains from elders with or without cognitive impairment. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 48: 1627-38. PMID 11101631 DOI: 10.1177/002215540004801206  0.44
2000 Arnold SE. Part III. Neuropathology of Alzheimer's disease. Disease-a-Month : Dm. 46: 687-705. PMID 11078010 DOI: 10.1016/S0011-5029(00)90030-0  0.44
2000 Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, Arnold SE, Bilker WB, Gur RC. Temporolimbic volume reductions in schizophrenia. Archives of General Psychiatry. 57: 769-75. PMID 10920465 DOI: 10.1001/Archpsyc.57.8.769  0.44
2000 Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Archives of General Psychiatry. 57: 761-8. PMID 10920464 DOI: 10.1001/Archpsyc.57.8.761  0.44
2000 Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 54: 1916-21. PMID 10822429 DOI: 10.1212/Wnl.54.10.1916  0.44
2000 Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE, Gur RE. Reduced olfactory bulb volume in patients with schizophrenia. The American Journal of Psychiatry. 157: 828-30. PMID 10784482 DOI: 10.1176/Appi.Ajp.157.5.828  0.44
2000 Falke E, Han LY, Arnold SE. Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia. Psychiatry Research. 93: 103-10. PMID 10725527 DOI: 10.1016/S0165-1781(00)00104-9  0.44
1999 Arnold SE. Cognition and neuropathology in schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 395: 41-50. PMID 10225332 DOI: 10.1111/J.1600-0447.1999.Tb05982.X  0.44
1999 Arnold SE, Trojanowski JQ, Parchi P. Protease resistant prion proteins are not present in sporadic "poor outcome" schizophrenia. Journal of Neurology, Neurosurgery, and Psychiatry. 66: 90-2. PMID 9886461 DOI: 10.1136/Jnnp.66.1.90  0.44
1998 Arnold SE, Smutzer GS, Trojanowski JQ, Moberg PJ. Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia. Annals of the New York Academy of Sciences. 855: 762-75. PMID 9929682 DOI: 10.1111/J.1749-6632.1998.Tb10656.X  0.44
1998 Tran KD, Smutzer GS, Doty RL, Arnold SE. Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. The American Journal of Psychiatry. 155: 1288-90. PMID 9734558 DOI: 10.1176/Ajp.155.9.1288  0.44
1998 Davies P, Resnick J, Resnick B, Gilman S, Growdon JH, Khachaturian ZS, Radebaugh TS, Roses AD, Selkoe DJ, Trojanowski JQ, Blass JP, Gibson GE, Sheu KFR, Blennow K, Delacourte A, ... ... Arnold SE, et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' Neurobiology of Aging. 19: 109-116. PMID 9558143 DOI: 10.1016/S0197-4580(98)00022-0  0.44
1997 Trojanowski JQ, Clark CM, Schmidt ML, Arnold SE, Lee VM. Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease. Neurobiology of Aging. 18: S75-9. PMID 9330990 DOI: 10.1016/S0197-4580(97)00075-4  0.4
1997 Moberg PJ, Doty RL, Mahr RN, Mesholam RI, Arnold SE, Turetsky BI, Gur RE. Olfactory identification in elderly schizophrenia and Alzheimer's disease. Neurobiology of Aging. 18: 163-7. PMID 9258893 DOI: 10.1016/S0197-4580(97)00015-8  0.44
1997 Moberg PJ, Doty RL, Turetsky BI, Arnold SE, Mahr RN, Gur RC, Bilker W, Gur RE. Olfactory identification deficits in schizophrenia: correlation with duration of illness. The American Journal of Psychiatry. 154: 1016-8. PMID 9210756 DOI: 10.1176/Ajp.154.7.1016  0.44
1997 Arnold SE, Joo E, Martinoli MG, Roy N, Trojanowski JQ, Gur RE, Cannon T, Price RA. Apolipoprotein E genotype in schizophrenia: frequency, age of onset, and neuropathologic features. Neuroreport. 8: 1523-6. PMID 9172167 DOI: 10.1097/00001756-199704140-00040  0.44
1997 Gurevich EV, Bordelon Y, Shapiro RM, Arnold SE, Gur RE, Joyce JN. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Archives of General Psychiatry. 54: 225-32. PMID 9075463 DOI: 10.1001/Archpsyc.1997.01830150047009  0.44
1997 Prohovnik I, Arnold SE, Smith G, Lucas LR. Physostigmine reversal of scopolamine-induced hypofrontality. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 220-8. PMID 9040502 DOI: 10.1097/00004647-199702000-00012  0.44
1996 Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathologica. 91: 269-77. PMID 8834539 DOI: 10.1007/S004010050425  0.44
1995 Martinoli MG, Trojanowski JQ, Schmidt ML, Arnold SE, Fujiwara TM, Lee VM, Hurtig H, Julien JP, Clark C. Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathologica. 90: 239-43. PMID 8525796 DOI: 10.1007/Bf00296506  0.44
1995 Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. The American Journal of Psychiatry. 152: 738-48. PMID 7726314 DOI: 10.1176/Ajp.152.5.738  0.44
1995 Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, Gur RC, Blackwell P, Trojanowski JQ. Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. The American Journal of Psychiatry. 152: 731-7. PMID 7726313 DOI: 10.1176/ajp.152.5.731  0.44
1994 Arnold SE, Hyman BT, Van Hoesen GW. Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease. Archives of Neurology. 51: 145-50. PMID 8304839 DOI: 10.1001/Archneur.1994.00540140051014  0.44
1994 Houlihan DJ, Flaum M, Arnold SE, Keshavan M, Alliger R. Further evidence for olfactory identification deficits in schizophrenia. Schizophrenia Research. 12: 179-82. PMID 8043528 DOI: 10.1016/0920-9964(94)90075-2  0.44
1994 Holdnack JA, Moberg PJ, Arnold SE, Gur RE, Gur RC. MMPI characteristics in adults diagnosed with ADD: a preliminary report. The International Journal of Neuroscience. 79: 47-58. PMID 7744550 DOI: 10.3109/00207459408986066  0.44
1991 Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry. 48: 625-32. PMID 2069493 DOI: 10.1001/Archpsyc.1991.01810310043008  0.44
1991 Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex (New York, N.Y. : 1991). 1: 103-16. PMID 1822725 DOI: 10.1093/Cercor/1.1.103  0.44
1991 Hyman BT, Flory JE, Arnold SE, Van Hoesen GW, Schelper RL, Ghanbari H, Haigler H. Quantitative assessment of ALZ-50 immunoreactivity in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 4: 231-5. PMID 1789912 DOI: 10.1177/089198879100400410  0.44
Show low-probability matches.